Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells

por Liu, Zhao, Qi, Shasha, Zhao, Xingbo, Li, Mingjiang, Ding, Sentai, Lu, Jiaju, Zhang, Hui
Publicado en Oncotarget (2016)

CCN3 (NOV) regulates proliferation, adhesion, migration and invasion in clear cell renal cell carcinoma

por LIU, SHUAI, LIU, ZHENG, BI, DONGBIN, YUAN, XAODONG, LIU, XIAOWEN, DING, SENTAI, LU, JIAJU, NIU, ZHIHONG
Publicado 2012

Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism

por Liu, Shuai, Gao, Mingwei, Wang, Xiaoqing, Ding, Sentai, Lv, Jiaju, Gao, Dexuan, Wang, Zhiyang, Niu, Zhihong
Publicado en Oncotarget (2016)

Different levels of estradiol are correlated with sexual dysfunction in adult men

por Chen, Tong, Wu, Fei, Wang, Xianlong, Ma, Gang, Xuan, Xujun, Tang, Rong, Ding, Sentai, Lu, Jiaju
Publicado en Sci Rep (2020)

Integrated Protein–Protein Interaction and Weighted Gene Co-expression Network Analysis Uncover Three Key Genes in Hepatoblastoma

por Tian, Linlin, Chen, Tong, Lu, Jiaju, Yan, Jianguo, Zhang, Yuting, Qin, Peifang, Ding, Sentai, Zhou, Yali
Publicado en Front Cell Dev Biol (2021)

Nephroblastoma overexpressed gene (NOV) enhances RCC cell motility through upregulation of ICAM-1 and COX-2 expression via Akt pathway

por Liu, Shuai, Han, Liping, Wang, Xiaoqing, Liu, Zheng, Ding, Sentai, Lu, Jiaju, Bi, Dongbin, Mei, Yikun, Niu, Zhihong
Publicado en Int J Clin Exp Pathol (2015)

Elevated expression of HIF-lα in actively growing prostate tissues is associated with clinical features of benign prostatic hyperplasia

por Wu, Fei, Ding, Sentai, Li, Xin, Wang, Hui, Liu, Shuai, Wu, Haihu, Bi, Dongbin, Ding, Kejia, Lu, Jiaju
Publicado en Oncotarget (2016)

Ubenimex enhances the radiosensitivity of renal cell carcinoma cells by inducing autophagic cell death

por Liu, Shuai, Wang, Xiaoqing, Lu, Jiaju, Han, Liping, Zhang, Yongfei, Liu, Zheng, Ding, Sentai, Liu, Zhao, Bi, Dongbin, Niu, Zhihong
Publicado en Oncol Lett (2016)

A Potent Chemotherapeutic Strategy with Eg5 Inhibitor against Gemcitabine Resistant Bladder Cancer

por Sun, Liang, Lu, Jiaju, Niu, Zhihong, Ding, Kejia, Bi, Dongbin, Liu, Shuai, Li, Jiamei, Wu, Fei, Zhang, Hui, Zhao, Zuohui, Ding, Sentai
Publicado en PLoS One (2015)

βKlotho inhibits androgen/androgen receptor-associated epithelial-mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling

por Liu, Zhao, Zhang, Hui, Ding, Sentai, Qi, Shasha, Liu, Shuai, Sun, Dingqi, Dong, Wei, Yin, Lei, Li, Mingjiang, Zhao, Xingbo, Lu, Jiaju
Publicado en Oncol Rep (2018)

Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA

por Zhao, Jing, Liu, Shuai, Gao, Dexuan, Ding, Sentai, Niu, Zhihong, Zhang, Hui, Huang, Zhilong, Qiu, Juhui, Li, Qing, Li, Ning, Xie, Fang, Cui, Jilei, Lu, Jiaju
Publicado en Oncotarget (2016)

Androgen Receptor Variants Mediate DNA Repair Following Radiation in Prostate Cancer

por Yin, Yi, Li, Rui, Xu, Kangling, Ding, Sentai, Li, Jeffrey, Baek, GuemHee, Ramanand, Susmita G., Ding, Sam, Liu, Zhao, Gao, Yunpeng, Kanchwala, Mohammed, Li, Xiangyi, Hutchinson, Ryan, Liu, Xihui, Woldu, Solomon, Xing, Chao, Desai, Neil B., Feng, Felix Y., Burma, Sandeep, de Bono, Johann, Dehm, Scott M., Mani, Ram S., Chen, Benjamin P.C., Raj, Ganesh V.
Publicado en Cancer Res (2017)